This Article Full Text Full Text (PDF) Other Versions of this Article: JCM.01381-07v1 46/1/62    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Larsen, A. R. Articles by Skov, R. Search for Related Content PubMed PubMed Citation Articles by Larsen, A. R. Articles by Skov, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2008, p. 62-68, Vol. 46, No. 1
0095-1137/08/$08.00+0     doi:10.1128/JCM.01381-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Epidemiology of European Community-Associated Methicillin-Resistant Staphylococcus aureus Clonal Complex 80 Type IV Strains Isolated in Denmark from 1993 to 2004

National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark,¹ Department of Medical Microbiology and Immunology, Saint Joseph Hospital, Creighton University Medical Center, Omaha, Nebraska²

Received 10 July 2007/ Returned for modification 21 August 2007/ Accepted 24 October 2007

In Europe, community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections have been caused predominantly by isolates belonging to the "European CA-MRSA" clone (sequence type 80, staphylococcal cassette chromosome mec type IV). In this study, the epidemiology of European CA-MRSA was investigated on a nationwide scale, covering the period from 1993 to 2004. Denmark has been a low-prevalence country regarding MRSA since the mid-1970s but has experienced an increase in the number of new MRSA cases in recent years. Our results show that European CA-MRSA contributed to this increase. The isolates primarily caused skin and soft tissue infections (SSTIs) in patients outside hospitals, and transmission between household members was the predominant mode of spread. Although some of the isolates were found in hospitalized patients, nosocomial transmission seemed likely in only one instance, pointing to endogenous infections as an important factor. Compared to the CA-MRSA clone most common in the United States (USA300), the European CA-MRSA clone seems less well adapted to persist in hospital environments. Patients with a recent history of travel or family relation to the Mediterranean or Middle East were highly overrepresented. The epidemiological data indicated that the European CA-MRSA isolates were introduced into Denmark on multiple occasions, paralleled by an increasing level of genetic diversity of the isolates found during the study period. European CA-MRSA has previously been described as a rather uniform clone. However, we found pronounced, diverse pulsed-field gel electrophoresis subtypes, staphylococcal protein A gene (spa) types, and susceptibility patterns.

Published ahead of print on 7 November 2007.

This article has been cited by other articles:

• Wolter, D. J., Chatterjee, A., Varman, M., Goering, R. V. (2008). Isolation and Characterization of an Epidemic Methicillin-Resistant Staphylococcus aureus 15 Variant in the Central United States. J. Clin. Microbiol. 46: 3548-3549 [Full Text]  
• Larsen, A. R., Skov, R. L., Jarlier, V., Henriksen, A. S. (2008). Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections. J Antimicrob Chemother 61: 589-594 [Abstract] [Full Text]